Takeda Biopharmaceuticals Achieves Great Place To Work® Certification in India

Takeda Biopharmaceuticals India Private Limited, a global leader in research and development-driven biopharmaceuticals, has been certified as a Great Place To Work® in India for the period between March 2023 and March 2024. The company, formerly known as Baxalta Bioscience India Pvt. Ltd., focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI).

The certification is awarded by Great Place To Work®, the global authority on workplace culture. The Institute serves businesses, non-profits, and government agencies in over 60 countries and has conducted pioneering research on the characteristics of great workplaces for more than three decades. In India, the institute partners with over 1400 organizations annually across 22 industries to help build High-Trust, High-Performance Cultures that deliver sustained business results.

Great Place To Work®’s research highlights that exceptional workplaces are characterized by strong leadership, consistent employee experience, and sustainable financial performance. Takeda India’s recognition as a Great Place to Work® demonstrates its commitment to fostering a positive work environment that drives employee engagement and business success.

Takeda’s employees are dedicated to improving the quality of life for patients and working with healthcare partners in approximately 80 countries and regions. The Great Place to Work® certification is a testament to the company’s efforts in creating a culture where employees can thrive and contribute to the organization’s mission and values.